Article Information
Corresponding author : Salma Ketata MD

Article Type : Case Report

Volume : 3

Issue : 3

Received Date : 21 Feb ,2022


Accepted Date : 03 Mar ,2022

Published Date : 10 Mar ,2022


DOI : https://doi.org/10.38207/JMCRCS/2022/MAR03030218
Citation & Copyright
Citation: Zouche I, Ketata S, Bayar NE, Feki S, triki Z (2022) Atypical Presentation of Amniotic Fluid Embolism: A case report. J Med Case Rep Case Series 3(03): https://doi.org/10.38207/JMCRCS/2022/MAR03030218

Copyright: © 2022 Salma Ketata MD. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credite
  Atypical Presentation of Amniotic Fluid Embolism: A case report

Imen Zouche MD1, Salma Ketata MD1*, Nour Elhouda Bayar MD2, Sarhan Feki MD1, Zied triki MD1

1Anesthesia department, Habib Bourguiba University Hospital of Sfax. SFAX, Tunisia

2Obstetric and gynecology department, Regional hospital of Kerkennah; Kerkennah, Sfax, Tunisia.

*Corresponding Author: Salma Ketata MD, Anesthesia department, Habib Bourguiba University Hospital of Sfax. SFAX, Tunisia

Abstract
Amniotic fluid embolism (AFE) is an acute, and unpredictable complication of pregnancy, with vital distress for the mother and fetus, that requires prompt recognition and supportive treatment.

We report a case of AFE after cesarean section, at the moment of the cord clamping, in a 28-year-old woman; resulting in respiratory distress; hemodynamic collapse; seizure, and without coagulopathy. The diagnosis was made after excluding differential diagnoses.

Management included 100 % oxygen delivery with a facial mask; hypovolemia correction is based on fluid resuscitation and low vasoconstrictors doses. Full recovery without sequelae was achieved in a few minutes.

Sometimes; AFE leads to serious complications and death while in others it may lead to mild organ dysfunction, and quick recovery. However, mild forms should be recognized early to avoid complications. A multidisciplinary experimented team combining anesthesiologists; obstetricians and neonatologists is essential to preserve maternal and fetal prognosis.

Keywords: Amniotic fluid embolism, diagnosis, management, Complications.

Introduction
Amniotic fluid embolism (AFE) is an acute, and unpredictable complication of pregnancy, with vital distress for the mother and fetus, occurring most often during labor or in immediate postpartum.[1–3].

Case Presentation
A 28-year-old woman, with no pathological history, first gesture first par, was admitted for cesarean section on a 39-week term of gestation because of the presence of a grade 4 anterior placenta previa.

At the arrival in the operative room, vital signs were normal

After 500 cc of crystalloids given, she had spinal anesthesia. The cold sense check was performed to verify the sensory block level to the fourth thoracic spinal segment. A hysterectomy was allowed and a 3370 g newborn was delivered with Apgar scores at 1 and 5 min at 7 and 9 respectively.

At the moment of the cord clamping, the patient felt vomiting and complained of dyspnea; O2 saturation decreased gradually, BP decreased to 45-65/20-30 mmHg, with an irregular pulse at 32 beat/min and parturient lost consciousness and convulsed. Her airway was managed with oxygen by facemask, and seizure activity stopped within 10– 15s without drug administration; at the same time a second peripheral intravenous access was obtained, ephedrine 12 mg and atropine 0.5 mg were injected. Then; the patient recovered to the sinus rhythm at 90b/min and BP at 124/75 mmHg and spontaneous breathing with SaO2 at 98 %. She was moved to the intensive care unit (UCI) where blood tests were performed (Table 1); Electrocardiogram, bedside chest, cardiac ultrasound, chest angiography, brain scan were all normal. The woman continued to recover with no neurological deficit. She was discharged home on the 5thday.

Table 1: Laboratory data of the blood sample obtained 2 h after delivery.

Test

value

Normal values

WBC

17,9 109/L

(3.5 109–9.5 109/L)

RBC

3,25 1012/ L

(3.8 1012–5.1 1012/L)

Hb

10,5 g/dL

(11,5–15g/dL)

Hct

30,7 %

(37 – 46 %)

Plt

110 109/L

(125 109–350 109/L)

PT

62 %

(75 %-100 %)

FIB

1,3 g/L

(2-4 g/L)

D-dimer

12.68 mg/L

(0.01–0.5 mg/L)

Troponin

734

(8-25)

Proteinuria

0g/24h

< 0.3g/24h

WBC: white blood; RBC: red blood cell counts; Hb: hemoglobin; Hct: hematocrit Plt: platelet counts; PT: prothrombin time; FIB: fibrinogen

Discussion
Physiopathology:
There are two theories explaining the pathogenesis of AFE:

A breach of the barrier between maternal blood and amniotic fluid allows the entry of amniotic fluid into the systemic circulation and results in mechanical obstruction of the pulmonary circulation.

Entry of amniotic fluid into the maternal circulation activates inflammatory mediators, causing a humoral or immunologic response. Amniotic fluid contains vasoactive and procoagulant products including platelet-activating factors, cytokines, bradykinin, thromboxane, leukotrienes, and arachidonic acid. Maternal plasma endothelin concentrations are increased by the entry of amniotic fluid. Endothelin is not only a bronchoconstrictor but also a pulmonary and coronary vasoconstrictor, which may contribute to respiratory and cardiovascular collapse. [2,4,5]

Clinical presentation:
The classic description of AFE includes sudden symptoms which involve many organ systems. The first phase is characterized by, respiratory distress, dyspnea, hypoxia, tachypnea, peripheral oxygen desaturation, decrease in end-tidal carbon dioxide in intubated patients, cyanosis, tachypnea, bronchospasm, pulmonary edema frequently and cardiovascular collapse and arrhythmia. Hypotension is the most frequent sign which occurs in 100 % of AFE.

Management
There is no specific treatment protocol unique to AFE. Anesthesiologist, neonatologist, and obstetrician must decide on a rapid cesarean section to deliver the baby. [3,5,7]

Hypoxemia must be managed by 100 % oxygen supplementation and airway management with tracheal intubation and positive pressure ventilation if necessary. [3,6,10,11]

A circulatory support must be accomplished by aggressive fluid resuscitation and vasopressor administration when necessary. Two large-bore intravenous cannulas and central venous access are recommended. [3,6]

Fluid administration needs to be monitored:

-An arterial catheter to monitor the blood pressure aiming a mean arterial pressure of greater than 65 mmHg. [6]

-Transthoracic or transesophageal echocardiography to manage fluid resuscitation and evaluate left ventricular filling.

-A pulmonary artery catheter, central venous pressure, pulmonary capillary wedge pressure, and pulmonary artery pressure to monitor cardiac output.

Encephalopathy seems to be a consequence of prolonged hypoxemia. The mental state is frequently altered, 10–50% of patients with AFE present with seizures. [2,3,5,6]

The second phase involves coagulopathy and hemorrhage. Disseminated intravascular coagulation (DIC) does not occur in all cases of AFE, [5,7] but causes the death of the patient even if appropriate cardiopulmonary resuscitation and bleeding management are performed. [6]

The last phase of AFE is characterized by tissue injury and end-organ system failure. [8]

Diagnosis:
The diagnosis of AFE is now based on the clinical features: hypoxia, hypotension, and coagulopathy occurring during labor; or within 30 minutes of placental delivery, and absence of fever [6].

Atypical manifestations of AFE include isolated coagulopathy with either a sudden or a gradual onset [9]. In some patients, DIC or uterine atony may be the only sign, [9,10] however DIC does not develop in all cases of AFE. [5] Our patient seems to be an atypical case of AFE. Blood tests, chest radiography, and echocardiogram help, but they are nonspecific.[9]

Those investigations were performed for our patient and were all normal. 

Urinary catheter to monitor urinary out pout aiming at least 0.5 mL/kg/h. [3,6,9]

During the resuscitation, left uterine displacement must be performed to decompress the inferior vena cava and improve preload and stroke volume until the baby will be delivered. [9,12]

Coagulopathy should be anticipated by blood and blood products administration including fresh frozen plasma (FFP), platelets, and cryoprecipitate. The optimal Red Blood cells (RBC) to FFP ratio is not known but given 1: 1–1.5 ratios is preferable. Blood tests such as complete blood count, electrolytes, coagulation studies, international normalization ratio, and fibrinogen must be repeated to evaluate the coagulopathy therapy. [2,3,6]The aim is to maintain a platelet count of over 50000/mm, a normal partial thromboplastin time, and a normal international normalization ratio[6]. The use of recombinant activated factor VIIa should be restricted to patients where hemorrhage cannot be managed by blood product administration [9] and its efficacy is controversial. [6,9]

Uterotonics should be administrated early. Insertion of Bakri catheter into the uterus to stop blood loss could be tried. Arterial embolization can be used. Hysterectomy is the ultimate solution to control bleeding. [3,5,9].

Key message
AFE seems to be a catastrophic complication unique to pregnancy. Classic clinical presentation is characterized by the tirade made by hypoxemia, hypovolemia, and coagulopathy, but atypical forms are not exceptional. The early recognition, prompt resuscitation and quick extraction of the baby improve both maternal and fetal prognosis.

Source(s)of support: None

Acknowledgment:
We thank the patient and her family for accepting to publish this case report. Nurses and personnel of the operating unit, surgical ward, obstetrics, and gynecology department, and anesthesiology department are acknowledged for their assistance and co-operation.

Presentation at a meeting: None

Conflicting Interest: The authors report no conflicts of interest in this work.

All authors declared that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and each the author believes that the manuscript represents honest work if that information is not provided in another form.

References

  1. Tamura N, Farhana M, Oda T, Itoh H, Kanayama N (2017) Amniotic fluid embolism: Pathophysiology from the perspective of pathology: The pathology of AFE. J Obstet Gynaecol Res. 43(4): 627-632.
  2. Sultan P, Seligman K, Carvalho B (2016) Amniotic fluid embolism: update and review. Curr Opin Anaesthesiol. 29(3): 288-96.
  3. Kaur K, Bhardwaj M, Kumar P, Singhal S, Singh T, et al. (2016) Amniotic fluid embolism. J Anaesthesiol Clin Pharmacol. 32(2): 153.
  4. Mahshid N, Ahmad S, Nahid M, Afshin F (2009) Sudden cardiac arrest during cesarean section -- a possible case of amniotic fluid embolism. Middle East J Anaesthesiol. 20(2): 315-7.
  5. Dean LS, Rogers RP 3rd, Harley RA, Hood D (2012) Case Scenario: Amniotic Fluid Embolism. Anesthesiology. 116(1): 186-92
  6. McBride A-M (2018) Clinical Presentation and Treatment of Amniotic Fluid Embolism. AACN Advanced Critical Care. 29(3): 336-342.
  7. Lee JH, Yang HJ, Kim J-H, Lee S-Y, Gill HJ, et al. (2010) Amniotic fluid embolism that took place during an emergent Cesarean section -A case report-. Korean J Anesthesiol. 59(Suppl): S158-62.
  8. Dean LS, Rogers RP, Harley RA, Hood DD, Riou B (2012) Case Scenario: Amniotic Fluid Embolism | Anesthesiology | ASA Publications. 116: 186–192
  9. Stawicki SA, Thongrong C, Kasemsiri P, Hofmann J, Bergese S, et al. (2013) Amniotic fluid embolism. International Journal of Critical Illness and Injury Science. 3(1): 51-7.
  10. Clark SL (2010) Amniotic Fluid Embolism: Clinical Obstetrics and Gynecology. 53(2): 322-8.
  11. Rudra A, Chatterjee S, Sengupta S, Nandi B, Mitra J (2009) Amniotic fluid embolism. Indian Journal of Critical Care Medicine. 13(3): 129.
  12.  Jeejeebhoy FM, Morrison LJ (2013) Maternal Cardiac Arrest: A Practical and Comprehensive Review. Emergency Medicine International. 2013: 274814.